Vivos Therapeutics Inc (VVOS)

Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.26% 3.419	3.248	3.301	3.395	3.857
Cost Of Revenue	0.10	-	0.10	0.10	0.10
Gross Profit	0.05% 1.937	1.938	1.898	2.098	2.337
Operating Expenses	8.04% 5.722	6.222	5.387	6.615	7.342
Benefits Costs and Expenses	73.77% 7.182	27.38	-	-	2.157
Costs And Expenses	88.06% 7.182	3.819	6.79	7.912	2.157
Depreciation and Amortization	2.01% 0.146	0.149	0.15	0.148	0.175
Operating Income/Loss	11.65% -3.785	-4.284	-3.489	-4.517	-5.005
Income/Loss From Continuing Operations Before Tax	84.41% -3.763	-24.14	3.301	-5.528	-1.703
Income/Loss From Continuing Operations After Tax	11.65% -3.763	-4.259	-2.093	-5.528	-1.703
Net Income/Loss	11.65% -3.763	-4.259	-2.093	-5.528	1.70
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,357% 2.3082	0.0668	1.1973	29.93	24.76
Diluted Average Shares	3,357% 2.3082	0.0668	1.1973	29.93	-1.6837
Basic Earnings Per Share	46.56% -1.63	-3.05	-1.75	-0.18	-0.07
Diluted Earnings Per Share	46.56% -1.63	-3.05	-1.75	-0.18	-0.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-